Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.705
+0.145 (4.07%)
At close: Aug 17, 2026, 4:00 PM EDT
3.770
+0.065 (1.75%)
After-hours: Aug 17, 2026, 7:55 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $265.54 million as of August 17, 2026. Its market cap has increased by 131.52% in one year.
Market Cap
265.54M
Enterprise Value
128.63M
1-Year Change
131.52%
Ranking
Category
Stock Price
$3.71
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $265.54M, a decrease of -54.80%. That is a compound annual growth rate of -11.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 265.54M | 203.78% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 270.95M |
| Lineage Cell Therapeutics | 270.61M |
| Entrada Therapeutics | 268.99M |
| MacroGenics | 268.81M |
| Cartesian Therapeutics | 267.46M |
| Orchestra BioMed Holdings | 265.06M |
| Whitehawk Therapeutics | 254.26M |
| Pyxis Oncology | 251.06M |